We are live on
!
Find out more
SGH
Sivik Global Healthcare Portfolio holdings
AUM
$132M
1-Year Est. Return
24.1%
This Fund
S&P 500
This Quarter
Est. Return
-2.58%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$210M
AUM Growth
+$11.3M
(+5.7%)
Cap. Flow
+$16.9M
Cap. Flow
% of AUM
8.06%
Top 10 Holdings %
Top 10 Hldgs %
36.19%
Holding
69
New
21
Increased
12
Reduced
17
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$9.56M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$6.83M |
| 3 |
Elevance Health
ELV
|
+$6.69M |
| 4 |
Gilead Sciences
GILD
|
+$5.95M |
| 5 |
McKesson
MCK
|
+$5.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$7.8M |
| 2 |
Amgen
AMGN
|
+$7.51M |
| 3 |
Medtronic
MDT
|
+$5.62M |
| 4 |
GSK
GSK
|
+$5.39M |
| 5 |
Eli Lilly
LLY
|
+$5.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 83.15% |
| 2 | Financials | 3.55% |
| 3 | Industrials | 1.31% |
| 4 | Consumer Staples | 0.98% |
| 5 | Energy | 0.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Puma Biotechnology
PBYI
$453M
| $921K | 0.44% |
+30,000
| New | +$1.3M |
|
|
AMED
52
DELISTED
Amedisys
AMED
| $917K | 0.44% |
21,510
-8,490
| -28% | -$361K |
|
|
KITE
53
DELISTED
Kite Pharma, Inc.
KITE
| $807K | 0.39% |
18,000
+3,000
| +20% | +$147K |
|
|
CLVS
54
DELISTED
Clovis Oncology, Inc.
CLVS
| $666K | 0.32% |
+15,000
| New | +$528K |
|
55
AbbVie
ABBV
$442B
| – | – |
-55,000
| Closed | -$3.47M |
|
|
56
Amgen
AMGN
$224B
| – | – |
-45,000
| Closed | -$7.51M |
|
57
Fresenius Medical Care
FMS
$12.7B
| – | – |
-40,000
| Closed | -$1.75M |
|
|
58
GSK
GSK
$102B
| – | – |
-100,000
| Closed | -$5.39M |
|
59
Integra LifeSciences
IART
$1.35B
| – | – |
-90,000
| Closed | -$3.71M |
|
60
Illumina
ILMN
$29.1B
| – | – |
-15,420
| Closed | -$2.73M |
|
|
61
Medtronic
MDT
$116B
| – | – |
-65,000
| Closed | -$5.62M |
|
62
Dr. Reddy's Laboratories
RDY
$10.4B
| – | – |
-150,000
| Closed | -$1.39M |
|
63
Revvity
RVTY
$12.9B
| – | – |
-40,000
| Closed | -$2.24M |
|
|
64
Zimmer Biomet
ZBH
$18.5B
| – | – |
-61,800
| Closed | -$7.8M |
|
65
Zoetis
ZTS
$31.1B
| – | – |
-35,000
| Closed | -$1.82M |
|
|
JUNO
66
DELISTED
Juno Therapeutics, Inc.
JUNO
| – | – |
-35,000
| Closed | -$1.05M |
|
|
SHPG
67
DELISTED
Shire pic
SHPG
| – | – |
-15,000
| Closed | -$2.91M |
|
Similar funds
AFP
TCPW
PCGDR
ACM
9C
STFP
ADEF
AC
Sivik Global Healthcare's Q4 2016 Portfolio in Review
As of Q4 2016, Sivik Global Healthcare held 69 positions worth $210M, up 5.7% from $198M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Sivik Global Healthcare deployed $16.9M of net new capital in Q4 2016, opening 21 new positions and adding to 12 existing holdings. Its largest new stake was iShares Biotechnology ETF: 105,000 shares worth $9.29M.
By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 91% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Eli Lilly, an estimated $5.21M trimmed.
- Sivik Global Healthcare's largest Q4 2016 buy was iShares Biotechnology ETF: 105,000 shares worth $9.29M.
- Sivik Global Healthcare added most to Aetna Inc in Q4 2016, an estimated $2.39M increase.
- Sivik Global Healthcare's biggest Q4 2016 reduction was Eli Lilly, cutting an estimated $5.21M.
- Sivik Global Healthcare fully exited Zimmer Biomet in Q4 2016, selling an estimated $7.8M.
- Sivik Global Healthcare's ten largest holdings make up 36% of its $210M portfolio in Q4 2016.
- Sivik Global Healthcare opened 21 new positions and closed 15 in Q4 2016.
- Sivik Global Healthcare's portfolio value rose 5.7% quarter-over-quarter to $210M.
Based on Sivik Global Healthcare's 13F filing for Q4 2016, filed 13 Feb 2017.